Use of complementary and alternative medicines among Malaysian cancer patients: A descriptive study

10.1016/j.jtcme.2014.12.008

Maryam Farooqui；Mohamed Azmi Hassali；Aishah Knight Abdul Shatar；Muhammad Aslam Farooqui；Fahad Saleem；Noman ul Haq；Che Noriah Othman

alternative medicines ； cancer ； complementary therapies ； disclosure ； Malaysia

Journal of Traditional and Complementary Medicine

6卷4期（2016 / 10 / 01）

321 - 326

英文

The use of Complementary and Alternative Medicine (CAM; 補充與替代醫學bǔ chōng yǔ tì dài yī xué) has been rapidly increasing among cancer patients. However, this pervasiveness is still largely unexplored among Malaysian cancer patients. The current study aimed to evaluate the patterns of CAM use among cancer patients from a local hospital in Malaysia. In addition, the study focused on the information-seeking behavior and CAM use disclosure to doctors. Of 393 patients, 184 (46.1%) had used CAM for their cancers. CAM usage was significantly associated with gender (p = 0.021), level of education (p = 0.001), employment status (p = 0.02), and monthly income (p ＜ 0.001). Among frequently used CAM were nutritional supplements (n = 77, 41.8%), natural products (n = 74, 40.2%), and multivitamin (n = 62, 33.6%). Friends and family members were the most common source of CAM information (n = 139, 75.5%). Seventy-nine (43%) reported to disclose their CAM use to the health care providers. The most common (n = 63, 34.2%) reason of nondisclosure was ＂it is not important to discuss it with oncologist.＂ This study confirmed that CAM use is common among Malaysian cancer patients, thus highlighting a greater need for patient education regarding CAM therapies and their potential interactions with conventional therapies. Although some types of CAM therapies may help patients to cope with emotional distress and improve quality of life, CAM, with no proven efficacy, may pose dangers to patients' health due to interactions with conventional therapies. Doctors and other health care providers including nurses and pharmacists should engage cancer patients in an open nonjudgmental dialog to ascertain CAM use disclosure to their health care providers.

1. Herbal Cancer Treatment: Sabah Snake Grass. Available from: http://goodguy.hubpages.com/hub/Herbal-cure-for-cancer. Accessed February 2012
2. Afifi, FU,Wazaify, M,Jabr, M,Treish, E(2010).The use of herbal preparations as complementary and alternative medicine (CAM) in a sample of patients with cancer in Jordan.Complement Ther Clin Pract,16,208-212.
3. Algier, LA,Hanoglu, Z,Ozden, G,Kara, F(2005).The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey.Eur J Oncol Nurs.,9,138-146.
4. Ali-Shtayeh, MS,Jamous, RM,Jamous, RM(2011).Herbal preparation use by patients suffering from cancer in Palestine.Complement Ther Clin Pract,17,235-240.
5. Behling, O,Law, KS(2000).Translating Questionnaires and Other Research Instruments: Problems and Solutions.London:Sage Publications, Inc..
6. Boon, H,Stewart, M,Kennard, MA(2000).Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions.J Clin Oncol,18,2515.
7. Chui, PL,Abdullah, KL,Wong, LP,Taib, NA(2014).Prayer-for-health and complementary alternative medicine use among Malaysian breast cancer patients during chemotherapy.BMC Complement Altern Med,14,425.
8. Corbin Winslow, L,Shapiro, H.(2002).Physicians want education about complementary and alternative medicine to enhance communication with their patients.Arch Intern Med.,162,1176-1181.
9. Daniel, WW(1999).Biostatistics: A Foundation for Analysis in the Health Sciences.New York:John Wiley & Sons.
10. Estrin, JT,Schocket, L,Kregenow, R,Henry, DH(1999).A retrospective review of blood transfusions in cancer patients with anemia.Oncologist,4,318-324.
11. Farooqui, M,Hassali, MA,Abdul, Shatar, AK,Shafie, AA,Seang, TB,Farooqui, MA(2012).Complementary and alternative medicine (CAM) use by Malaysian oncology patients.Complement Ther Clin Pract,18,114-120.
12. Farooqui, M,Hassali, MA,Shatar, AK,Shafie, AA,Seang, TB,Farooqui, MA(2011).A qualitative exploration of Malaysian cancer patients' perspectives on cancer and its treatment.BMC Public Health,11,525.
13. Ganasegeran, K,Rajendran, AK,Al-Dubai, SAR(2014).Psycho-socioeconomic factors affecting complementary and alternative medicine use among selected rural communities in Malaysia: a cross-sectional study.PloS One,9,e112124.
14. Glaspy, J.(2001).Anemia and fatigue in cancer patients.Cancer,92,1719-1724.
15. Groopman, JE,Itri, LM(1999).Chemotherapy-induced anemia in adults: incidence and treatment.J Natl Cancer Inst,91,1616-1634.
16. Hamidah, A,Rustam, ZA,Tamil, AM,Zarina, LA,Zulkifli, ZS,Jamal, R(2009).Prevalence and parental perceptions of complementary and alternative medicine use by children with cancer in a multi-ethnic Southeast Asian population.Pediatr Blood Cancer,52,70-74.
17. Helyer, L,Chin, S,Chui, B(2006).The use of complementary and alternative medicines among patients with locally advanced breast cancer-a descriptive study.BMC Cancer,6,39.
18. Hyodo, I,Amano, N,Eguchi, K(2005).Nationwide survey on complementary and alternative medicine in cancer patients in Japan.J Clin Oncol.,23,2645-2654.
19. Johnstone, PA(2011).Acupuncture as cancer symptom therapy: what a difference a decade makes.J Acupunct Meridian Stud,4,209-213.
20. Kremser, T,Evans, A,Moore, A(2008).Use of complementary therapies by Australian women with breast cancer.Breast,17,387-394.
21. Little, CV(2009).Simply because it works better. Exploring motives for the use of medical herbalism in contemporary UK health care.Complement Ther Med,17,300-308.
22. Lua, PL.(2011).The role of complementary indigenous Malay therapies. Perspectives from palliative care patients.J Complement Integr Med,8,16.
23. Mao, JJ,Farrar, JT,Xie, SX,Bowman, MA,Armstrong, K(2007).Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer.Complement Ther Med,15,21-29.
24. Micke, O,Bruns, F,Glatzel, M(2009).Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology.Eur J Integ Med.,1,19-25.
25. Ministry of Health Malaysia. National Policy on Traditional/Complementary Medicine. Available from: http://tcm.moh.gov.my/v4/. Accessed November 2011.
26. National Centre for Complementary and Alternative Medicine. Expanding Horizons of Health Care. What is CAM? Available from: http://nccam.nih.gov/health/.Accessed November 2011.
27. Rezaei, M,Adib-Hajbaghery, M,Seyedfatemi, N,Hoseini, F(2008).Prayer in Iranian cancer patients undergoing chemotherapy.Complement Ther Clin Pract,14,90-97.
28. Sabah Snake Grass. Available from: http://www.sabahsnakegrassherb.com/2013/03/present-for-nutans-also-known-as-sabah.html. Accessed December 2013.
29. Santos, JRA(1999).Cronbach's alpha: a tool for assessing the reliability of scales.J Extension,37,1-5.
30. Sewitch, MJ,Rajput, Y(2010).A literature review of complementary and alternative medicine use by colorectal cancer patients.Complement Ther Clin Pract,6,52-56.
31. Shen, J,Andersen, R,Albert, P(2002).Use of complementary/alternative therapies by women with advanced-stage breast cancer.BMC Complement Altern Med,2,8.
32. Shih, V,Chiang, JYL,Chan, A(2009).Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients.Ann Oncol,20,752-757.
33. Sibbritt, D,Adams, J,Easthope, G,Young, A(2003).Complementary and alternative medicine (CAM) use among elderly Australian women who have cancer.Support Care Cancer,11,548-550.
34. Sirois, FM,Gick, ML(2002).An investigation of the health beliefs and motivations of complementary medicine clients.Soc Sci Med.,55,1025-1037.
35. Siti, ZM,Tahir, A,Farah, AI(2009).Use of traditional and complementary medicine in Malaysia: a baseline study.Complement Ther Med,17,292-299.
36. Swisher, EM,Cohn, DE,Goff, BA(2002).Use of complementary and alternative medicine among women with gynecologic cancers.Gynecol Oncol.,84,363-367.
37. Thomson, P,Jones, J,Evans, JM,Leslie, SL(2012).Factors influencing the use of complementary and alternative medicine and whether patients inform their primary care physician.Complement Ther Med,20,45-53.
38. Vadiraja, HS,Rao, MR,Nagarathna, R(2009).Effects of yoga program on quality of life and affect in early breast cancer patients undergoing adjuvant radio-therapy: a randomized controlled trial.Complement Ther Med,17,274-280.
39. Verhoef, M,Trojan, L,Armitage, G,Carlson, L,Hilsden, RJ(2009).Complementary therapies for cancer patients: assessing information use and needs.Chronic Dis Can,29,80-88.
40. Verhoef, MJ,White, MA(2002).Factors in making the decision to forgo conventional cancer treatment.Cancer Pract,10,201-207.
41. Wanikiat, P,Panthong, A,Sujayanon, P,Yoosook, C,Rossi, AG,Reutrakul, V(2008).The anti-inflammatory effects and the inhibition of neutrophil responsiveness by Barleria lupulina and Clinacanthus nutans extracts.J Ethnopharmacol,116,234-244.
42. World Health Organization (WHO). Media Centre. Traditional Medicine, Fact sheet N134; December 2008. Available from: http://www.who.int/mediacentre/factsheets/2003/fs134/en/. Accessed November 2011.
43. Yates, JS,Mustian, KM,Morrow, GR(2005).Prevalence of complementary and alternative medicine use in cancer patients during treatment.Support Care Cancer,13,806-811.
44. Yates, PT,Beadle, G,Clavarino, A(1993).Patients with terminal cancer who use alternative therapies: their beliefs and practices.Social Health Illn,15,199-216.
45. Yoosook, C,Panpisutchai, Y,Chaichana, S,Santisuk, T,Reutrakul, V(1999).Evaluation of anti-HSV-2 activities of Barleria lupulina and Clinacanthus nutans.J Ethnopharmacol,67,179-187.

1. Sohelia Zareifar,Sezaneh Haghpanah,Sanaz Safaei,Roza kamfiroozi,Omidreza zekavat,Mohammadreza Bordbar,Mehdi Pasalar(2018).Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study.Journal of Traditional and Complementary Medicine,8(1),141-146.